EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Chemical and Biological Determinants of PEG‐Lipid Shedding From Therapeutic Nanoparticles

Ethan P Cisneros iD, Aadya S Wijesekera, Lisa R Volpatti iD

Small · 2026-10 · 22 (58)

DOI: 10.1002/smll.75613 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Small, online erschienen am 10.09.2026. Verfasst von Ethan P Cisneros und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Northwestern University, Evanston, Illinois, USA. Hauptthemen laut MEDLINE: Polyethylene Glycols, Nanoparticles, Lipids. Die Arbeit nennt 216 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health Training.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polyethylene glycol (PEG)‐lipids are widely used to engineer the interfacial properties of lipid‐based nanomaterials, where they play a central role in governing colloidal stability and biological interactions. By forming a steric barrier at the nanoparticle surface, PEG‐lipids reduce protein adsorption and extend circulation times. Additionally, PEG‐lipids are increasingly functionalized with targeting moieties, representing a primary strategy to enable selective delivery. However, accumulating evidence indicates that PEG‐lipids are not static components but instead undergo dynamic dissociation, or “shedding,” upon exposure to biological environments. This interfacial exchange process alters nanoparticle behavior, promoting protein adsorption and accelerating clearance, while also enabling cellular interactions that facilitate uptake. Here, we present a conceptual framework for understanding PEG‐lipid shedding as a coupled thermodynamic and kinetic process influenced by lipid chemical structure, nanocarrier membrane properties, and interactions with biomolecules. By synthesizing recent findings across experimental systems, we identify key factors that link PEG‐lipid composition and nanoparticle architecture to desorption kinetics and biological outcomes. These insights provide guidance for the design of PEGylated nanomaterials with improved control over interfacial stability, immune recognition, and functional performance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polyethylene GlycolsNanoparticlesLipidsAnimalsHumans

Stichwörter der Autor:innen

PEG‐lipidsdrug deliveryformulationimmunoengineeringnanoparticle

Substanzen

Polyethylene GlycolsLipids

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Northwestern University, Evanston, Illinois, USA.
  • Department of Chemical and Biological Engineering, Northwestern University, Evanston, Illinois, USA.
  • Biohub, Chicago, Illinois, USA.
  • International Institute for Nanotechnology, Northwestern University, Evanston, Illinois, USA.

ORCID-Profile: Ethan P Cisneros, Lisa R Volpatti

Förderung

  • NIGMS NIH HHS
  • National Institutes of Health Training

Zitieren

APA

Cisneros, E. P., Wijesekera, A. S., & Volpatti, L. R. (2026). Chemical and Biological Determinants of PEG‐Lipid Shedding From Therapeutic Nanoparticles. Small, 22(58). https://doi.org/10.1002/smll.75613

Vancouver

Cisneros EP, Wijesekera AS, Volpatti LR. Chemical and Biological Determinants of PEG‐Lipid Shedding From Therapeutic Nanoparticles. Small. 2026;22(58). doi:10.1002/smll.75613

BibTeX
@article{Cisneros2026,
  author = {Cisneros, Ethan P and Wijesekera, Aadya S and Volpatti, Lisa R},
  title = {Chemical and Biological Determinants of PEG‐Lipid Shedding From Therapeutic Nanoparticles},
  journal = {Small},
  year = {2026},
  volume = {22},
  number = {58},
  doi = {10.1002/smll.75613}
}
Kostenlos starten →